Mana Capital Acquisition Corp.
MAAQ
NASDAQ Global Market5.99
USD
-1.91
- -
Mana Capital Acquisition Corp.
MAAQ
(NASDAQ Global Market)
Recent
price
5.99
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Mana Capital Acquisition Corp. is a special purpose acquisition company (SPAC) established by Mana Capital Group with a primary focus on effecting business combinations with high-growth companies, particularly in the digital assets, blockchain technology, decentralized finance (DeFi), and fintech sectors. The company completed its initial public offering in 2021 and operates primarily in North America while also evaluating global opportunities that align with its investment thesis. Mana Capital Acquisition’s strategy centers on identifying targets that leverage emerging technologies to innovate financial services, providing public investors access to leading companies in the evolving digital economy. It holds IPO proceeds in a trust account pending a qualifying transaction and benefits from the expertise of professionals in finance, technology, and corporate transactions from its sponsor, Mana Capital Group. In a significant recent development, Mana Capital Acquisition Corp. completed a reverse merger transaction with Cardio Diagnostics Holdings, Inc. in October 2022. This transaction resulted in the company becoming Cardio Diagnostics Holdings, Inc., a precision cardiovascular medicine company that utilizes a proprietary Integrated Genetic-Epigenetic Engine™ combining artificial intelligence and epigenetics to enable improved prevention, early detection, and treatment of cardiovascular diseases. The combination has shifted the company’s operational focus explicitly to cardiovascular solutions with a strong emphasis on biotechnology and medical technology sectors. Founded as a Delaware corporation, Mana Capital Acquisition functions as a blank check company aimed at mergers, asset acquisitions, stock exchanges, and recapitalizations. The company’s key team members have backgrounds in investment banking, private equity, and technology, supporting its growth and acquisition strategies. The successful business combination with Cardio Diagnostics marked a major operational shift, transitioning from a SPAC to an operating company dedicated to advanced diagnostics in cardiovascular health. Thus, Mana Capital Acquisition Corp. had initially provided investors with access to emerging digital finance technologies but recently transformed fundamentally through its 2022 merger, now emphasizing precision cardiovascular diagnostics using AI-driven genetic and epigenetic technology, headquartered in Delaware with a broad North American and expanding global orientation. This pivot reflects its latest major company change and strategic expansion into the biotechnology sector.